According to BlockBeats, MEI Pharma, a company listed on the U.S. stock market, has announced its rebranding to Litecoin Strategy, with the new Nasdaq ticker symbol LITS. Following the announcement, the company's stock price saw an intraday increase of 10.61%, bringing its market capitalization to approximately $101 million.